pyridoxal phosphate has been researched along with Liver Neoplasms in 99 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
Liver Neoplasms: Tumors or cancer of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to study the effects of serum folate and plasma pyridoxal 5'-phosphate (PLP) on plasma homocysteine, oxidative stress and antioxidant capacities in 44 hepatocellular carcinoma (HCC) patients and 56 healthy controls." | 7.83 | Folate and vitamin B-6 status are not associated with homocysteine, oxidative stress and antioxidant capacities in patients with hepatocellular carcinoma. ( Cheng, SB; Huang, YC; Lai, CY; Lin, PT; Liu, HT, 2016) |
| "To determine the efficacy of manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate) (DPDP) at magnetic resonance (MR) imaging for evaluation of hepatocellular carcinoma (HCC)." | 5.08 | Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP). ( Baron, RL; Confer, SR; Davis, PL; Federle, MP; Murakami, T; Oliver, JH; Peterson, MS, 1996) |
| "The purpose of this study was to study the effects of serum folate and plasma pyridoxal 5'-phosphate (PLP) on plasma homocysteine, oxidative stress and antioxidant capacities in 44 hepatocellular carcinoma (HCC) patients and 56 healthy controls." | 3.83 | Folate and vitamin B-6 status are not associated with homocysteine, oxidative stress and antioxidant capacities in patients with hepatocellular carcinoma. ( Cheng, SB; Huang, YC; Lai, CY; Lin, PT; Liu, HT, 2016) |
| "Rats fed diets deficient in choline develop hepatocellular carcinoma." | 3.79 | Prediagnostic levels of serum one-carbon metabolites and risk of hepatocellular carcinoma. ( Arning, E; Bottiglieri, T; Butler, LM; Gao, YT; Govindarajan, S; Wang, R; Yuan, JM, 2013) |
| "Twenty-one patients with 39 hepatocellular carcinomas underwent ferumoxides-enhanced and mangafodipir trisodium-enhanced MR imaging." | 2.70 | Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced versus mangafodipir trisodium-enhanced MR imaging. ( Choi, D; Kim, H; Kim, SH; Kim, SK; Lee, SJ; Lee, WJ; Lim, HK; Lim, JH; Seo, JW, 2002) |
| " Adverse events were reported for 23% of the patients; most were mild to moderate in intensity, did not require treatment, and were not drug related." | 2.69 | Safety and efficacy of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials (safety). ( Anderson, MW; Borello, JA; Bova, JG; Brown, JJ; Chezmar, JL; Dachman, AH; Federle, MP; Fenstermacher, M; Foster, GS; Francis, IR; Freeny, PC; Halford, HH; Harmon, B; Harms, SE; Johnson, CD; Kenney, PJ; Klippenstein, DL; Lee, JK; Mattrey, R; Mitchell, DG; Pelsang, RE; Rubin, DL; Saini, S; Semelka, RC; Turner, DA; Weinreb, JC, 2000) |
| "Fifty patients with liver cirrhosis and histologically proven HCC were enrolled in a prospective phase-IIIB clinical trial." | 2.69 | MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis. ( Bartolozzi, C; Cioni, D; Crocetti, L; Donati, F; Lencioni, R, 2000) |
| "Intrahepatic thrombus is usually associated with either cirrhosis or hepatocellular carcinoma (HCC)." | 2.68 | Tumoural portal vein thrombosis. Enhancement with MnDPDP. ( Anglade, MC; Coffin, C; Lonjedo, E; Marti-Bonmati, L; Mathieu, D; Poyatos, C, 1997) |
| " Adverse events and discomfort were recorded and graded in all patients." | 2.42 | Safety and efficacy of Mangafodipir trisodium in patients with liver lesions and cirrhosis. ( de Beeck, BO; Fagertun, H; Fog, AF; Kane, P; Martí-Bonmatí, L, 2003) |
| "We used cultured human hepatoma cells and evaluated static intracellular profiles of amino acids and in vivo kinetics of H2S biomarker formation." | 1.40 | Vitamin B-6 restriction reduces the production of hydrogen sulfide and its biomarkers by the transsulfuration pathway in cultured human hepatoma cells. ( Banerjee, R; Chi, YY; DeRatt, BN; Gregory, JF; Kabil, O; Ralat, MA, 2014) |
| "Hypotonicity triggered in human hepatoma cells (Huh-7) the release of ATP and cell swelling, followed by volume regulatory decrease (RVD)." | 1.39 | On the role of ATP release, ectoATPase activity, and extracellular ADP in the regulatory volume decrease of Huh-7 human hepatoma cells. ( Alberti, GS; Alvarez, CL; Davio, C; de Tezanos Pinto, F; Espelt, MV; Incicco, J; Leal Denis, MF; Schwarzbaum, PJ, 2013) |
| "The lesions in hepatocellular carcinomas patients showed a non-homogeneous enhancement pattern." | 1.33 | Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images. ( Adigüzel, Y; Haykir, R; Karabacakoğlu, A; Karaköse, S; Kayaçetin, E, 2006) |
| "Forty-six patients with 96 hepatocellular carcinomas underwent Mn-DPDP- and gadopentetate dimeglumine-enhanced MRI." | 1.32 | MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents. ( Kim, CS; Lee, JM; Youk, JH, 2004) |
| "Hepatocyte-containing liver neoplasms such as hepatomas or focal nodular hyperplasia (FNH), take up MnDPDP and demonstrate varying degrees of enhancement." | 1.31 | MnDPDP enhanced magnetic resonance imaging of focal liver lesions. ( Burkill, GJ; Healy, JC; King, LJ; Murray-Lyons, I; Scurr, ED; Vlavianos, P, 2002) |
| "These two cases had hepatocellular carcinoma and fibrolamellar hepatocellular carcinoma, respectively, confirmed on liver biopsy." | 1.31 | Technical report: lymph node enhancement at MRI with MnDPDP in primary hepatic carcinoma. ( Burkill, GJ; Healy, JC; Mannion, EM, 2001) |
| "Hepatic angiomyolipomas are rare and often mimic other liver tumors." | 1.31 | Correlation of MRI and CT findings with histopathology in hepatic angiomyolipoma. ( Flemming, P; Galanski, M; Högemann, D; Kreipe, H, 2001) |
| "A total of 69 primary and secondary liver cancers from these three animal models were studied." | 1.29 | Experimental liver cancers: Mn-DPDP-enhanced rims in MR-microangiographic-histologic correlation study. ( Baert, AL; Lodemann, KP; Marchal, G; Ni, Y; Rummeny, E; Yu, J; Zhang, X, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (12.12) | 18.7374 |
| 1990's | 30 (30.30) | 18.2507 |
| 2000's | 49 (49.49) | 29.6817 |
| 2010's | 7 (7.07) | 24.3611 |
| 2020's | 1 (1.01) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, W | 1 |
| Butrin, A | 1 |
| Melani, RD | 1 |
| Doubleday, PF | 1 |
| Ferreira, GM | 1 |
| Tavares, MT | 1 |
| Habeeb Mohammad, TS | 1 |
| Beaupre, BA | 1 |
| Kelleher, NL | 1 |
| Moran, GR | 1 |
| Liu, D | 1 |
| Silverman, RB | 1 |
| Espelt, MV | 1 |
| de Tezanos Pinto, F | 1 |
| Alvarez, CL | 1 |
| Alberti, GS | 1 |
| Incicco, J | 1 |
| Leal Denis, MF | 1 |
| Davio, C | 1 |
| Schwarzbaum, PJ | 1 |
| Butler, LM | 1 |
| Arning, E | 1 |
| Wang, R | 1 |
| Bottiglieri, T | 1 |
| Govindarajan, S | 1 |
| Gao, YT | 1 |
| Yuan, JM | 1 |
| DeRatt, BN | 1 |
| Ralat, MA | 2 |
| Kabil, O | 1 |
| Chi, YY | 1 |
| Banerjee, R | 1 |
| Gregory, JF | 2 |
| Cheng, SB | 1 |
| Liu, HT | 1 |
| Lin, PT | 1 |
| Lai, CY | 1 |
| Huang, YC | 1 |
| Kim, JH | 3 |
| Kim, MJ | 5 |
| Park, YN | 1 |
| Lee, JT | 2 |
| Kim, BR | 1 |
| Chung, JB | 1 |
| Choi, JS | 2 |
| Kim, KS | 1 |
| Kim, KW | 6 |
| Rockall, AG | 1 |
| Planche, K | 1 |
| Power, N | 1 |
| Nowosinska, E | 1 |
| Monson, JP | 1 |
| Grossman, AB | 1 |
| Reznek, RH | 1 |
| Ni, Y | 3 |
| Wang, H | 1 |
| Chen, F | 1 |
| Li, J | 1 |
| DeKeyzer, F | 1 |
| Feng, Y | 1 |
| Yu, J | 2 |
| Bosmans, H | 2 |
| Marchal, G | 3 |
| Kulemann, V | 1 |
| Schima, W | 4 |
| Tamandl, D | 1 |
| Kaczirek, K | 1 |
| Gruenberger, T | 1 |
| Wrba, F | 2 |
| Weber, M | 1 |
| Ba-Ssalamah, A | 2 |
| Zhao, M | 1 |
| da Silva, V | 1 |
| Garrett, TJ | 1 |
| Melnyk, S | 1 |
| James, SJ | 1 |
| Burke, C | 1 |
| Alexander Grant, L | 1 |
| Goh, V | 1 |
| Griffin, N | 1 |
| Kim, SK | 1 |
| Kim, SH | 2 |
| Lee, WJ | 2 |
| Kim, H | 1 |
| Seo, JW | 1 |
| Choi, D | 1 |
| Lim, HK | 1 |
| Lee, SJ | 1 |
| Lim, JH | 1 |
| Sahani, DV | 3 |
| Saini, S | 8 |
| Kalra, MK | 1 |
| Michael, M | 1 |
| Hahn, PF | 4 |
| Cresens, E | 1 |
| Adriaens, P | 1 |
| Dymarkowski, S | 1 |
| Bogaert, J | 1 |
| Zhang, H | 1 |
| Verbruggen, A | 1 |
| Rieger, J | 1 |
| Körner, M | 1 |
| Linsenmaier, U | 1 |
| Rock, C | 1 |
| Wirth, S | 1 |
| Pfeifer, KJ | 1 |
| Burkill, GJ | 3 |
| King, LJ | 2 |
| Scurr, E | 2 |
| Healy, JC | 3 |
| Scurr, ED | 1 |
| Vlavianos, P | 1 |
| Murray-Lyons, I | 1 |
| Wang, DB | 1 |
| Zhou, KR | 1 |
| Zeng, MS | 1 |
| Chen, KM | 1 |
| Wang, YX | 1 |
| Martí-Bonmatí, L | 2 |
| Fog, AF | 1 |
| de Beeck, BO | 1 |
| Kane, P | 1 |
| Fagertun, H | 2 |
| Traoré, AS | 1 |
| Godbout, MJ | 1 |
| Serre, D | 1 |
| Younan, R | 1 |
| Dionne, G | 1 |
| Dufour, M | 1 |
| Morin, J | 1 |
| Moisan, C | 1 |
| Guo, T | 1 |
| Zhang, XL | 1 |
| Chang, RM | 1 |
| Zhang, YZ | 1 |
| ITO, K | 2 |
| NAKAHARA, I | 2 |
| SAKAMOTO, Y | 2 |
| Bedda, S | 1 |
| Laurent, A | 1 |
| Conti, F | 1 |
| Chéreau, C | 1 |
| Tran, A | 1 |
| Tran-Van Nhieu, J | 1 |
| Jaffray, P | 1 |
| Soubrane, O | 1 |
| Goulvestre, C | 1 |
| Calmus, Y | 1 |
| Weill, B | 1 |
| Batteux, F | 1 |
| Bartolozzi, C | 2 |
| Donati, F | 2 |
| Cioni, D | 2 |
| Procacci, C | 1 |
| Morana, G | 1 |
| Chiesa, A | 1 |
| Grazioli, L | 1 |
| Cittadini, G | 2 |
| Giovagnoni, A | 1 |
| Gandini, G | 1 |
| Maass, J | 1 |
| Lencioni, R | 2 |
| Reimer, P | 1 |
| Schneider, G | 1 |
| Kim, AY | 1 |
| Kim, TK | 1 |
| Park, SH | 1 |
| Kim, HJ | 2 |
| Lee, YK | 1 |
| Park, MS | 1 |
| Ha, HK | 1 |
| Kim, PN | 2 |
| Kim, JC | 1 |
| Lee, MG | 2 |
| Beziat, C | 1 |
| Pilleul, F | 1 |
| Yzebe, D | 1 |
| Lombard-Bohas, C | 1 |
| Mercier, C | 1 |
| Valette, PJ | 1 |
| Youk, JH | 1 |
| Lee, JM | 1 |
| Kim, CS | 1 |
| Lim, JS | 2 |
| Oh, YT | 2 |
| Chung, JJ | 4 |
| Happel, B | 1 |
| Kettenbach, J | 1 |
| Dirisamer, A | 1 |
| Längle, F | 1 |
| Kalva, SP | 2 |
| Fischman, AJ | 2 |
| Kadavigere, R | 1 |
| Blake, M | 1 |
| Ryan, D | 1 |
| Mueller, P | 1 |
| Tanimoto, A | 1 |
| Kuribayashi, S | 1 |
| Kanematsu, M | 1 |
| Kondo, H | 1 |
| Goshima, S | 1 |
| Kato, H | 1 |
| Tsuge, U | 1 |
| Hirose, Y | 1 |
| Moriyama, N | 1 |
| Regge, D | 1 |
| Campanella, D | 1 |
| Anselmetti, GC | 1 |
| Cirillo, S | 1 |
| Gallo, TM | 1 |
| Muratore, A | 1 |
| Capussotti, L | 1 |
| Galatola, G | 1 |
| Floriani, I | 1 |
| Aglietta, M | 1 |
| Byun, JH | 1 |
| Won, HJ | 1 |
| Shin, YM | 1 |
| Lee, MS | 1 |
| Eser, G | 1 |
| Karabacakoglu, A | 2 |
| Karakose, S | 2 |
| Eser, C | 1 |
| Kayacetin, E | 2 |
| Choi, JY | 1 |
| Ko, HK | 1 |
| Yoo, HS | 1 |
| Adigüzel, Y | 1 |
| Haykir, R | 1 |
| Koh, DM | 3 |
| Brown, G | 3 |
| Meer, Z | 1 |
| Norman, AR | 1 |
| Husband, JE | 2 |
| Riddell, AM | 1 |
| Collins, DJ | 1 |
| Allen, SD | 1 |
| Chau, I | 1 |
| Cunningham, D | 2 |
| deSouza, NM | 1 |
| Leach, MO | 1 |
| Kong, G | 1 |
| Jackson, C | 1 |
| Lewington, V | 1 |
| Sharma, B | 1 |
| Cook, GJ | 1 |
| Liou, J | 1 |
| Lee, JK | 4 |
| Borrello, JA | 2 |
| Brown, JJ | 3 |
| Rummeny, E | 3 |
| Zhang, X | 1 |
| Lodemann, KP | 2 |
| Baert, AL | 1 |
| Rofsky, NM | 2 |
| Weinreb, JC | 2 |
| Bernardino, ME | 2 |
| Young, SW | 2 |
| Noz, ME | 1 |
| Mitchell, DG | 3 |
| Murakami, T | 2 |
| Baron, RL | 2 |
| Federle, MP | 3 |
| Peterson, MS | 2 |
| Oliver, JH | 2 |
| Davis, PL | 2 |
| Confer, SR | 2 |
| Earls, JP | 1 |
| Slater, GJ | 1 |
| Mayo-smith, WW | 1 |
| Sharma, P | 1 |
| Eisenberg, PJ | 1 |
| Chezmar, JL | 2 |
| Redvanly, RD | 1 |
| Sewell, CW | 1 |
| Padovani, B | 1 |
| Lecesne, R | 1 |
| Raffaelli, C | 1 |
| Chevallier, P | 1 |
| Drouillard, J | 1 |
| Bruneton, JN | 1 |
| Lambrechts, M | 1 |
| Gordon, P | 1 |
| Kettritz, U | 1 |
| Schlund, JF | 1 |
| Wilbur, K | 1 |
| Eisenberg, LB | 1 |
| Semelka, RC | 5 |
| Torres, CG | 2 |
| Lundby, B | 2 |
| Sterud, AT | 1 |
| McGill, S | 2 |
| Gordon, PB | 1 |
| Bjerknes, HS | 1 |
| Kane, PA | 1 |
| Ayton, V | 1 |
| Walters, HL | 1 |
| Benjamin, I | 1 |
| Heaton, ND | 1 |
| Williams, R | 2 |
| Karani, JB | 1 |
| Rummeny, EJ | 2 |
| Kurdziel, JC | 1 |
| Nilsen, G | 1 |
| Op de Beeck, B | 1 |
| Wang, C | 2 |
| Ahlström, H | 1 |
| Ekholm, S | 1 |
| Hellström, M | 1 |
| Hemmingsson, A | 1 |
| Holtås, S | 1 |
| Isberg, B | 1 |
| Jonnson, E | 1 |
| Lönnemark-Magnusson, M | 1 |
| Wallengren, NO | 1 |
| Westman, L | 1 |
| Lonjedo, E | 1 |
| Mathieu, D | 3 |
| Coffin, C | 2 |
| Poyatos, C | 1 |
| Anglade, MC | 1 |
| Jung, G | 2 |
| Heindel, W | 1 |
| Krahe, T | 1 |
| Kugel, H | 1 |
| Walter, C | 1 |
| Fischbach, R | 1 |
| Klaus, H | 1 |
| Lackner, K | 1 |
| Coffin, CM | 1 |
| Diche, T | 2 |
| Mahfouz, A | 2 |
| Alexandre, M | 1 |
| Caseiro-Alves, F | 2 |
| Rahmouni, A | 2 |
| Vasile, N | 1 |
| Kobeiter, H | 1 |
| Rubin, DL | 2 |
| Freeny, PC | 1 |
| Borello, JA | 1 |
| Mattrey, R | 2 |
| Dachman, AH | 2 |
| Harmon, B | 2 |
| Fenstermacher, M | 1 |
| Pelsang, RE | 1 |
| Harms, SE | 2 |
| Halford, HH | 2 |
| Anderson, MW | 2 |
| Johnson, CD | 1 |
| Francis, IR | 2 |
| Bova, JG | 1 |
| Kenney, PJ | 1 |
| Klippenstein, DL | 1 |
| Foster, GS | 1 |
| Turner, DA | 1 |
| Federle, M | 1 |
| Chezmar, J | 2 |
| Weinreb, J | 1 |
| Freeny, P | 1 |
| Schmiedl, UP | 1 |
| Bennett, WF | 1 |
| Rifkin, M | 1 |
| Gay, SB | 1 |
| Ballerini, R | 2 |
| Sherwin, PF | 1 |
| Robison, RO | 1 |
| Crocetti, L | 1 |
| Martin, DR | 1 |
| Balci, NC | 1 |
| Wilber, K | 1 |
| Mannion, EM | 1 |
| Joarder, R | 1 |
| de Jode, M | 1 |
| Lamb, GA | 1 |
| Gedroyc, WM | 1 |
| Grimm, J | 1 |
| Müller-Hülsbeck, S | 1 |
| Blume, J | 1 |
| Biederer, J | 1 |
| Heller, M | 1 |
| Mann, GN | 1 |
| Marx, HF | 1 |
| Lai, LL | 1 |
| Wagman, LD | 1 |
| Högemann, D | 1 |
| Flemming, P | 1 |
| Kreipe, H | 1 |
| Galanski, M | 1 |
| De Gaspari, A | 1 |
| De Cobelli, F | 1 |
| Del Maschio, A | 1 |
| Helmberger, T | 1 |
| Iciek, MB | 1 |
| Rokita, HB | 1 |
| Wlodek, LB | 1 |
| Helmberger, TK | 1 |
| Laubenberger, J | 1 |
| Sievers, K | 1 |
| Döhring, W | 1 |
| Meurer, K | 1 |
| Reiser, MF | 1 |
| Seltzer, SE | 1 |
| Getty, DJ | 1 |
| Pickett, RM | 1 |
| Swets, JA | 1 |
| Sica, G | 1 |
| Brown, J | 1 |
| Mattrey, RF | 1 |
| Schnall, MO | 1 |
| Siegelman, ES | 1 |
| Bhat, S | 1 |
| Oka, T | 1 |
| Vogl, TJ | 3 |
| Hammerstingl, R | 1 |
| Schnell, B | 3 |
| Eibl-Eibesfeldt, B | 2 |
| Peqios, W | 1 |
| Lissner, J | 3 |
| Hamm, B | 3 |
| Branding, G | 1 |
| Taupitz, M | 1 |
| Wolf, KJ | 1 |
| Kopp, AF | 1 |
| Laniado, M | 2 |
| Aicher, KP | 1 |
| Grönewäller, EF | 1 |
| Claussen, CD | 1 |
| Steudel, A | 2 |
| Layer, G | 1 |
| Kraheck, H | 1 |
| Hartlapp, J | 1 |
| Reiser, M | 1 |
| Mühler, A | 1 |
| Clément, O | 1 |
| Vexler, V | 1 |
| Berthezène, Y | 1 |
| Rosenau, W | 1 |
| Brasch, RC | 1 |
| Peters, PE | 1 |
| Steiner, S | 1 |
| Ehrenheim, C | 1 |
| Gehl, HB | 1 |
| Schmiedel, E | 1 |
| Vogl, TG | 1 |
| Zaman, SN | 1 |
| Tredger, JM | 1 |
| Johnson, PJ | 1 |
| Herzfeld, A | 1 |
| Knox, WE | 1 |
| Bukin, IuV | 1 |
| Sergeev, AV | 1 |
| Raushenbakh, MO | 1 |
| Hosoda, S | 1 |
| Nakamura, W | 1 |
| Snell, KC | 1 |
| Stewart, HL | 1 |
| Grigo, KM | 1 |
| Von Redlich, D | 1 |
| Glick, D | 1 |
| Goriukhina, TA | 1 |
| Lebedeva, SB | 1 |
| Harik, SI | 1 |
| Hollenberg, MD | 1 |
| Snyder, SH | 1 |
| Rej, R | 1 |
| Fasce, CF | 1 |
| Vanderlinde, RE | 1 |
| Fujimoto, S | 1 |
| Miyoshi, T | 1 |
| Nomura, Y | 1 |
| Akao, T | 1 |
| Ito, B | 1 |
11 reviews available for pyridoxal phosphate and Liver Neoplasms
| Article | Year |
|---|---|
The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
Topics: Bile Duct Neoplasms; Bile Ducts; Contrast Media; Edetic Acid; Gadolinium DTPA; Hepatocytes; Humans; | 2013 |
Safety and efficacy of Mangafodipir trisodium in patients with liver lesions and cirrhosis.
Topics: Contrast Media; Edetic Acid; Female; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Magne | 2003 |
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neopl | 2004 |
[MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents].
Topics: Chelating Agents; Contrast Media; Edetic Acid; Gadolinium; Humans; Image Enhancement; Image Interpre | 2004 |
Imaging liver metastases: review and update.
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Hepatic Artery; Humans; Imag | 2006 |
Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
Topics: Adrenal Gland Diseases; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clini | 1996 |
Unexpected MR-T1 enhancement of endocrine liver metastases with mangafodipir.
Topics: Adenoma, Islet Cell; Contrast Media; Edetic Acid; Humans; Liver; Liver Neoplasms; Magnetic Resonance | 1999 |
[Magnetic resonance imaging of the liver: what kind of contrast agents?].
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Focal Nodular Hyperplasia; Gadolinium DT | 2001 |
New contrast agents for imaging the liver.
Topics: Animals; Contrast Media; Edetic Acid; Ferric Compounds; Ferrosoferric Oxide; Gadolinium; Gadolinium | 2001 |
[Some new aspects of the function of spermidine in animal cells].
Topics: Adenosylmethionine Decarboxylase; Animals; Breast; Cell Division; Chick Embryo; Female; Glucocortico | 1975 |
[Status and development of new clinical contrast media for MR diagnosis of liver diseases].
Topics: Acetates; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Mag | 1992 |
30 trials available for pyridoxal phosphate and Liver Neoplasms
| Article | Year |
|---|---|
Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced versus mangafodipir trisodium-enhanced MR imaging.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Dextrans; Edetic Acid; False Negative Reacti | 2002 |
[Focal secondary malignant liver lesions: MnDPDP-enhanced MRT at 0.2 tesla vs. helical CT-arterioportography].
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Image Enhancement; Liver Neoplasms; Magnet | 2002 |
Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Edetic Acid; Female; Humans; Liver Neoplasms; Mag | 2004 |
[Detection of liver metastases in colorectal cancer on chemotherapy. Comparative study between MRI with teslascan and computed tomography with intravenous contrast media].
Topics: Aged; Colorectal Neoplasms; Contrast Media; Edetic Acid; Feasibility Studies; Humans; Injections; Io | 2004 |
Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Dextrans; Edetic Acid; Female; Ferrosoferric Oxid | 2006 |
Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarc | 2006 |
Detection of hepatic metastasis: manganese- and ferucarbotran-enhanced MR imaging.
Topics: Adult; Aged; Contrast Media; Dextrans; Edetic Acid; Female; Ferrosoferric Oxide; Humans; Image Enhan | 2006 |
Diagnostic accuracy of rim and segmental MRI enhancement of colorectal hepatic metastasis after administration of mangafodipir trisodium.
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Edetic Acid; Female; Humans; Image Enhancement; L | 2007 |
Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; | 1993 |
Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP).
Topics: Case-Control Studies; Contrast Media; Edetic Acid; Female; Humans; Image Processing, Computer-Assist | 1996 |
Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Confidence Intervals; Contrast Media; Ede | 1996 |
Mn-DPDP enhanced MR imaging of the liver: analysis of pulse sequence performance.
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Image Enhancement; Liver; Liver Diseases; | 1996 |
Uptake of mangafodipir trisodium (MnDPDP) by hepatocellular carcinoma: correlation with unenhanced imaging findings and histopathologic features.
Topics: Adult; Biopsy; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Humans; Image Enhancement; Li | 1996 |
Tolerability and utility of mangafodipir trisodium injection (MnDPDP) at the dose of 5 mumol/kg body weight in detecting focal liver tumors: results of a phase III trial using an infusion technique.
Topics: Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Female; Humans; Infusions, Intravenous; Live | 1996 |
MnDPDP for MR imaging of the liver. Results from the European phase III studies.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Europe; Female; Humans; Liver; Liver Ne | 1997 |
MnDPDP-enhanced MR imaging of the liver. Correlation with surgical findings.
Topics: Adolescent; Adult; Aged; Animals; Contrast Media; Edetic Acid; Female; Guinea Pigs; Humans; Liver; L | 1997 |
MnDPDP for MR imaging of the liver. Results of an independent image evaluation of the European phase III studies.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Europe; Female; Humans; Liver; Liver Ne | 1997 |
Diagnostic efficacy of MnDPDP in MR imaging of the liver. A phase III multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Female; Humans; Liver; Liver Neoplasms; | 1997 |
Tumoural portal vein thrombosis. Enhancement with MnDPDP.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Female; Humans; Liv | 1997 |
Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging.
Topics: Adenoma, Liver Cell; Adult; Aged; Biopsy, Needle; Carcinoma, Hepatocellular; Contrast Media; Diagnos | 1999 |
Safety and efficacy of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. multicenter phase III clinical trials (safety).
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Contrast Media; Diagnosis, | 2000 |
Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Humans | 2000 |
MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis.
Topics: Carcinoma, Hepatocellular; Edetic Acid; Female; Follow-Up Studies; Humans; Iodized Oil; Liver Cirrho | 2000 |
[Comparison of biphasic spiral CT and MnDPDP-enhanced MRI in the detection and characterization of liver lesions].
Topics: Adenoma; Adult; Aged; Biopsy; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cysts; Diagnosis, Diffe | 2001 |
MRI characteristics in focal hepatic disease before and after administration of MnDPDP: discriminant analysis as a diagnostic tool.
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Contrast | 2002 |
Multimodality diagnosis of liver tumors: feature analysis with CT, liver-specific and contrast-enhanced MR, and a computer model.
Topics: Adult; Carcinoma, Hepatocellular; Computer Simulation; Contrast Media; Edetic Acid; Humans; Liver Ne | 2002 |
[Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].
Topics: Biliary Tract Diseases; Biliary Tract Neoplasms; Cholangiography; Contrast Media; Edetic Acid; Gadol | 1992 |
Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Evaluation Studies as Topic; Fe | 1992 |
[Manganese DPDP as a contrast medium for MR tomography of focal liver lesions. Tolerance and image quality in 20 patients].
Topics: Adult; Contrast Media; Drug Tolerance; Edetic Acid; Female; Humans; Liver Neoplasms; Magnetic Resona | 1992 |
[Manganese-DPDP in the MR tomography of malignant liver tumors. The initial results with a new hepatobiliary contrast agent].
Topics: Adult; Aged; Contrast Media; Drug Evaluation; Edetic Acid; Humans; Infusions, Intravenous; Liver; Li | 1992 |
58 other studies available for pyridoxal phosphate and Liver Neoplasms
| Article | Year |
|---|---|
Rational Design, Synthesis, and Mechanism of (3
Topics: 4-Aminobutyrate Transaminase; Carboxylic Acids; Enzyme Inhibitors; gamma-Aminobutyric Acid; Humans; | 2022 |
On the role of ATP release, ectoATPase activity, and extracellular ADP in the regulatory volume decrease of Huh-7 human hepatoma cells.
Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Azo Compounds; Brefeldin A | 2013 |
Prediagnostic levels of serum one-carbon metabolites and risk of hepatocellular carcinoma.
Topics: Aged; Animals; Carcinoma, Hepatocellular; Case-Control Studies; Choline; Cohort Studies; Humans; Liv | 2013 |
Vitamin B-6 restriction reduces the production of hydrogen sulfide and its biomarkers by the transsulfuration pathway in cultured human hepatoma cells.
Topics: Alanine; Biomarkers; Carcinoma, Hepatocellular; Cysteine; Hep G2 Cells; Homocysteine; Humans; Hydrog | 2014 |
Folate and vitamin B-6 status are not associated with homocysteine, oxidative stress and antioxidant capacities in patients with hepatocellular carcinoma.
Topics: Aged; Antioxidants; Carcinoma, Hepatocellular; Female; Folic Acid; Glutathione Peroxidase; Glutathio | 2016 |
Mangafodipir trisodium-enhanced MRI of hepatocellular carcinoma: correlation with histological characteristics.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Cell Differentiation; Contrast Media; Edetic Acid; Female; H | 2008 |
Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI.
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Iohexol; Liver Neoplasms; Magnetic Resonan | 2009 |
Tumor models and specific contrast agents for small animal imaging in oncology.
Topics: Animals; Biomarkers, Tumor; Clinical Trials as Topic; Contrast Media; Diagnostic Imaging; Disease Mo | 2009 |
Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI?
Topics: Aged; Colorectal Neoplasms; Contrast Media; Dextrans; Edetic Acid; Fatty Liver; Female; Gadolinium D | 2011 |
Vitamin B-6 restriction impairs fatty acid synthesis in cultured human hepatoma (HepG2) cells.
Topics: Carcinoma, Hepatocellular; Cell Membrane; Delta-5 Fatty Acid Desaturase; Down-Regulation; Fatty Acid | 2013 |
Liver lesion detection and characterization with sequential use of hepatobiliary contrast agent mangafodipir trisodium and gadolinium-DTPA in a single imaging protocol.
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic | 2002 |
Exploring multifunctional features of necrosis avid contrast agents.
Topics: Animals; Contrast Media; Edetic Acid; Gadolinium DTPA; Half-Life; Liver Diseases; Liver Neoplasms; M | 2002 |
Breast carcinoma metastases to the liver simulating cirrhosis.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Contrast Media; Edetic Acid; Female; Humans; Liver Cirr | 2002 |
MnDPDP enhanced magnetic resonance imaging of focal liver lesions.
Topics: Adenoma, Liver Cell; Adult; Aged; Cholangiocarcinoma; Contrast Media; Edetic Acid; Female; Focal Nod | 2002 |
[Organ specific MRI contrast media in general practice].
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Humans; Iron; Liver Neoplasms; Lung Neop | 2002 |
Mn-DPDP-enhanced 24-h delayed-scan MRI of hepatocellular carcinoma is correlated with histology.
Topics: Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Humans; Liver; Liver Neoplasms; Magnetic Res | 2004 |
Improved image contrast with mangafodipir trisodium (MnDPDP) during MR-guided percutaneous cryosurgery of the liver.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Contrast Media; Cryosurgery; Edetic Acid; Fema | 2003 |
[Comparative study of four GRE sequences in MnDPDP-enhanced magnetic resonance imaging for primary hepatocellular carcinoma].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Female; Humans; Image Enhanceme | 2003 |
[STUDIES ON VITAMIN B6 METABOLISM OF CANCER CELLS AND TUMOR-BEARING RAT LIVER. I. ENZYME ACTIVITIES RELATED TO VITAMIN B6 METABOLISM].
Topics: Carcinoma, Hepatocellular; Flavin Mononucleotide; Liver; Liver Neoplasms; Metabolism; Neoplasms, Exp | 1964 |
[STUDIES ON VITAMIN B6 METABOLISM OF CANCER CELLS AND TUMOR-BEARING RAT LIVER. II. UPTAKE OF PYRIDOXINE DERIVATIVES BY TUMOR CELLS AND THE LIVER OF TUMOR-BEARING RATS].
Topics: Carcinoma, Hepatocellular; Liver; Liver Neoplasms; Neoplasms; Neoplasms, Experimental; Permeability; | 1964 |
Mangafodipir prevents liver injury induced by acetaminophen in the mouse.
Topics: Acetaminophen; Animals; Antibodies, Monoclonal; Antioxidants; Carcinoma, Hepatocellular; Caspase 3; | 2003 |
Small (
Topics: Adult; Aged; Colorectal Neoplasms; Contrast Media; Edetic Acid; Female; Humans; Liver; Liver Neoplas | 2004 |
MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; | 2004 |
Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Topics: Adult; Aged; Contrast Media; Dextrans; Diagnosis, Differential; Edetic Acid; Female; Ferrosoferric O | 2004 |
Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Colonic Neoplasms; Contrast Media; Edetic Acid; Female; Fluorodeoxygluc | 2005 |
Detection of liver metastases from gastrointestinal cancer: comparision of high resolution MnDPDP enhanced MRI and FDG-PET.
Topics: Adenocarcinoma; Adult; Aged; Contrast Media; Edetic Acid; Female; Fluorodeoxyglucose F18; Gastrointe | 2005 |
Hepatocyte-targeted MR contrast agents: contrast enhanced detection of liver cancer in diffusely damaged liver.
Topics: Animals; Carbon Tetrachloride; Contrast Media; Dextrans; Edetic Acid; Female; Ferrosoferric Oxide; H | 2005 |
Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Contrast Media; Edetic Acid; Female; Humans; L | 2006 |
Mangafodipir trisodium-enhanced magnetic resonance imaging for evaluation of pancreatic mass and mass-like lesions.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Female; Humans; Liver N | 2006 |
Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarc | 2006 |
Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination.
Topics: Aged; Colorectal Neoplasms; Contrast Media; Diffusion Magnetic Resonance Imaging; Edetic Acid; Femal | 2008 |
The use of 18F-FDG PET/CT in colorectal liver metastases--comparison with CT and liver MRI.
Topics: Aged; Colorectal Neoplasms; Contrast Media; Edetic Acid; False Positive Reactions; Female; Fluorodeo | 2008 |
Differentiation of hepatomas from nonhepatomatous masses: use of MnDPDP-enhanced MR images.
Topics: Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Edetic Acid; Hemangioma, Caverno | 1994 |
Experimental liver cancers: Mn-DPDP-enhanced rims in MR-microangiographic-histologic correlation study.
Topics: Angiography; Animals; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Liver Neoplasms; Liver | 1993 |
Hepatobiliary contrast material: a magic bullet for sensitivity and specificity?
Topics: Contrast Media; Edetic Acid; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Pyridoxal Phosphat | 1993 |
Comparison of gadolinium chelates with manganese-DPDP for liver lesion detection and characterization: preliminary results.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Cysts; Edetic Acid; Female; Gadolinium; Gado | 1996 |
Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Topics: Adenocarcinoma; Adenoma, Islet Cell; Adipose Tissue; Adult; Aged; Aged, 80 and over; Blood-Brain Bar | 1998 |
Influence of the hepatobiliary contrast agent mangafodipir trisodium (MN-DPDP) on the imaging properties of abdominal organs.
Topics: Abdomen; Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Kidney; Liver; Liver Diseases; Li | 1998 |
Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions: initial observations.
Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Focal Nodular Hyperplasia | 2000 |
Technical report: lymph node enhancement at MRI with MnDPDP in primary hepatic carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Humans; Liver Neoplasms; Lympha | 2001 |
The value of MnDPDP enhancement during MR guided laser interstitial thermoablation of liver tumors.
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Laser Coagulation; Liver Neoplasms; Magnet | 2001 |
Clinical and cost effectiveness of a new hepatocellular MRI contrast agent, mangafodipir trisodium, in the preoperative assessment of liver resectability.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Contrast Media; Cost-Benefit Analysis; Edetic Acid; Fema | 2001 |
Correlation of MRI and CT findings with histopathology in hepatic angiomyolipoma.
Topics: Adult; Aged; Angiomyolipoma; Contrast Media; Edetic Acid; Female; Gadolinium DTPA; Humans; Liver; Li | 2001 |
Effects of diallyl disulfide and other donors of sulfane sulfur on the proliferation of human hepatoma cell line (HepG2).
Topics: Allyl Compounds; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Division; Cystamine; Disulfi | 2001 |
Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
Topics: Acetates; Animals; Bile; Contrast Media; Duodenum; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; | 1992 |
Contrast-enhanced MR imaging of the liver.
Topics: Contrast Media; Edetic Acid; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Pyridoxal P | 1992 |
[The clinical value of Mn-DPDP: a new paramagnetic hepatobiliary contrast medium for magnetic resonance tomography of the liver].
Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Drug Evaluation; Edetic Acid; Female; Humans; | 1991 |
Manganese-DPDP as a hepatobiliary contrast agent in the magnetic resonance imaging of liver tumors. Results of clinical phase II trials in Germany including 141 patients.
Topics: Biliary Tract; Contrast Media; Drug Evaluation; Drug Tolerance; Edetic Acid; Germany; Humans; Liver; | 1991 |
Clinical hepatic imaging with paramagnetic positive enhancers.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Hemangioma; Humans; Liver; Liver Neoplasms | 1991 |
Vitamin B6 concentrations in patients with chronic liver disease and hepatocellular carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Humans; Liver Diseases; Liver Neoplasms; Middle | 1986 |
The properties, developmental formation, and estrogen induction of ornithine aminotransferase in rat tissues.
Topics: Animals; Carcinoma, Hepatocellular; Castration; Enzyme Induction; Estradiol; Female; Fetus; Intestin | 1968 |
[New route of regulating folic acid metabolism in experimental chemotherapy of leukoses and malignant neoplasms].
Topics: Animals; Carcinoma, Hepatocellular; Cycloserine; Female; Folic Acid; Leukemia, Experimental; Liver; | 1971 |
Histidine decarboxylase in the transplantable argyrophilic gastric carcinoid of Praomys (Mastomys) natalensis.
Topics: Ammonium Sulfate; Animals; Carboxy-Lyases; Carcinoid Tumor; Carcinoma, Ehrlich Tumor; Carcinoma, Hep | 1971 |
Fluorometric determination of pyridoxal phosphate in microgram samples of tissue.
Topics: Adrenal Glands; Animals; Carcinoid Tumor; Carcinoma, Hepatocellular; Cattle; Cyanides; Evaluation St | 1972 |
[Isoenzyme spectrum of serine transoxymethylase in the liver and in hepatomas].
Topics: Agar; Animals; Carbon Isotopes; Carcinoma, Hepatocellular; Electrophoresis; Gels; Glycine; Isoenzyme | 1973 |
Ornithine decarboxylase turnover slowed by alpha-hydrazino-ornithine.
Topics: Animals; Brain; Carbon Radioisotopes; Carboxy-Lyases; Carcinoma, Hepatocellular; Cycloheximide; Dith | 1974 |
Increased aspartate aminotransferase activity of serum after in vitro supplementation with pyridoxal phosphate.
Topics: Adult; Aspartate Aminotransferases; Aspartic Acid; Carcinoma, Squamous Cell; Colorimetry; Cytoplasm; | 1973 |
Intra-arterial cancer chemotherapy with combined anticancer agents.
Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Cytarabine; Deoxycytidine; Drug Therapy, Combination | 1973 |